| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $277.2M | +9.7% |
| R&D Expense | $138.5M | +29.9% |
| SG&A Expense | $146.4M | +54.7% |
| Operating Income | -$275.9M | -54.0% |
| Pre-tax Income | -$269.7M | -50.7% |
| Income Tax | $64K | +101.2% |
| Net Income | -$270.4M | -53.4% |
| EPS (Basic) | -$0.99 | -43.5% |
| EPS (Diluted) | -$0.99 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $538.5M | -27.8% |
| Accounts Receivable | $58.4M | +13.6% |
| Inventory | $8.7M | +16.0% |
| Current Assets | $626.6M | -24.3% |
| Total Assets | $1.22B | -15.8% |
| Current Liabilities | $114.1M | -19.5% |
| Total Liabilities | $133.7M | -27.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$192.3M | -35.9% |
| Capital Expenditures | $292K | -47.8% |
| Investing Cash Flow | -$11.6M | +80.5% |
| Financing Cash Flow | -$3.6M | -162.8% |
| Free Cash Flow | -$192.6M | -35.6% |
| -43.5% |
| Stockholders' Equity |
| $1.06B |
| -14.2% |